It is well established that hip fractures can increase mortality among osteoporosis patients, but a new study conducted in Oregon found that this injury puts elderly women at a much greater risk of death within the year following the fracture.
Data presented at the annual conference of the American Society for Bone and Mineral Research (ASBMR) indicates that male osteoporosis patients who suffer one vertebral pressure fracture have a significantly increased risk of experiencing another.
Though initially approved by the U.S. Food and Drug Administration (FDA) for use among osteoporosis patients, zoledronic acid may double as a life-extending therapy for older women with breast cancer.
While heredity is known to play a major role in an individual's likelihood of developing osteoporosis, until recently scientists could only point to a handful of genes that appear to confer this risk. However, all that has begun to change.
While bisphosphonates are currently prescribed as a treatment for osteoporosis, one variety of the medication may soon be repurposed as a pain reliever for prostate cancer patients with bone metastases.
While bisphosphonates and other osteoporosis medications are not meant to be taken for decades on end, some physicians recommend that patients who respond well to several years of such pharmaceutical treatments consider taking a "drug holiday."
While light alcohol consumption does not harm bone health, multiple studies have shown that heavy drinking can drastically interfere with bone turnover and accelerate the onset of osteoporosis.
Most osteoporosis patients are aware of the individual physical impact of sticking to their treatment regimen, but it can be harder to conceptualize the economic savings that broad adherence to medications can have.
Many physiological factors affect the rate at which bones break down and reform their mineral content, but new research conducted at the University of California, Los Angeles (UCLA) suggested that socioeconomic status (SES) may also have some bearing on bone turnover and the risk of osteoporosis.
Bone density tests are typically considered an invaluable tool for the diagnosis of osteoporosis, but new research suggests that physicians may be able to ballpark a patient's risk of hip fracture without resorting to bone scans.
Numerous public health authorities recommend that osteoporosis patients exercise as a way to build both bone and muscle, and now a seminal study has demonstrated that this skeleton-strengthening effect may be due to the way that physical activity activates certain stem cells.
Osteoporosis affects at least 2 million American males, according to the National Osteoporosis Foundation (NOF), but a new investigation revealed that older men are unlikely to see primary care physicians or seek treatment for bone loss following a fracture.
The concept of osteoporosis as a preventable, human-centric disease is a relatively new notion with a long formative history, one that a pair of Norwegian recently spelled out in an issue of the journal Science, Technology and Human Values.
Having a dedicated osteoporosis coordinator may help individuals with low bone density pursue the medical attention and preventive care they need following a low-impact fracture.
Dual-emission X-ray absorptiometry (DXA) scans are currently the gold standard for osteoporosis detection, but new bone health exams are developed each year, like a toenail clipping-based test being created by an Irish medical technology firm.